NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



Researchers detail new studies and findings in the area of breast cancer



May 12th, 2005

Breast cancer data are the focus of recent research from the United States.

Study 1: Specialists in nuclear medicine at Yeshiva University's Albert Einstein College of Medicine report that in a mouse model of breast cancer, positron therapy with F-18-2-deoxy-2-fluoro-D-glucose significantly prolonged survival and decreased mammary tumor growth rate compared to controls.

R.M. Moadel and colleagues wrote, "Novel therapies are needed for [breast cancer] patients when standard treatments are ineffective. We have recently shown on a cellular level the therapeutic potential of positrons in malignancy. Here, we report for the first time positron therapy...


Source: Women's Health Weekly (2005-05-12)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login